Healthcare demand is relatively inelastic compared with discretionary retail, and digital access often becomes more attractive when households optimize for convenience and value. Telehealth is not recession-proof, but the channel has defensive traits: care need persists, virtual delivery reduces friction, and refill-driven subscription models tie revenue to ongoing therapy rather than one-time purchases. This article compares telehealth's structural traits to other asset classes, walks through COVID-era utilization evidence, and explains what recession resilience does and does not mean for clinic owners underwriting cash flow.
What happens to healthcare spending in a recession?
A recession is commonly described as two consecutive quarters of declining GDP. Discretionary retail and big-ticket purchases usually fall first. Healthcare does not behave like luxury travel. People still need medications, chronic care, mental health support, and follow-ups. They may delay elective procedures, but refill-driven and condition-management demand is stickier.
Historical patterns from CMS and academic health economics research show healthcare spending growth may slow in severe downturns, but total demand rarely collapses the way discretionary categories do. Households trade down, shop for value, and shift channels before they stop treating chronic conditions. That channel shift is where telehealth often gains share.
What typically compresses vs what holds
- More elastic: Elective procedures, cosmetic-adjacent care, discretionary wellness add-ons.
- More resilient: Maintenance medications, mental health treatment, weight-health programs where stopping has visible health costs.
- Mixed: Cash-pay categories where patients weigh monthly subscription cost against perceived benefit.
Digital clinics with clear clinical anchoring and transparent pricing often outperform vague wellness offers when budgets tighten because patients can justify ongoing spend.
Why does digital care tend to hold up when budgets tighten?
Three structural reasons show up repeatedly in payer and utilization research:
- Lower friction: No travel, less time off work, faster access for many follow-ups and medication pathways.
- Value seeking: Patients compare cash-pay and subscription options more carefully, which favors clear online offers with predictable monthly pricing.
- Lower fixed clinic overhead for digital models: A virtual brand does not carry the same real-estate burden as a multi-site brick-and-mortar network.
That does not mean every telehealth brand wins. It means the channel has defensive characteristics relative to many discretionary categories. For the broader market context, start with U.S. telehealth market size in 2026.
What did COVID teach us about demand shocks?
2020 was not a classic financial-crisis recession, but it was a severe demand and access shock. CDC reporting and major health-system data showed telemedicine visits surged as in-person capacity constrained, then partially normalized. Critically, a share of that adoption stuck. Patients who learned to complete consults and refills remotely often kept using those pathways.
The lesson for capital allocators is behavioral, not purely macroeconomic. When access breaks or convenience dominates, patients adopt virtual care quickly. When conditions normalize, they do not fully revert. That stickiness supports the thesis that digital clinics are not only pandemic artifacts, which matters when underwriting through cycles.
Utilization pattern in plain language
Pre-2020 baselines were low for many specialties. 2020 spiked to multiples of prior levels. 2021 through 2023 cooled but settled above 2019 in numerous payer datasets. Post-peak virtual share remains meaningful for medication management, behavioral health, and consumer categories such as weight-health, where GLP-1 demand reshaped telehealth funnels.
How does telehealth compare with other places capital goes?
Recession resilience is relative. Telehealth clinics still face acquisition cost inflation, policy risk, and retention leaks. Compared with common alternatives, the pattern looks like this:
- Public equities: Major drawdowns of 20% to 40% have been common in severe risk-off periods for broad indexes.
- Commercial real estate: Vacancies and valuation pressure rise when tenants struggle.
- Discretionary e-commerce SKUs: Mix shifts toward value, but many categories still compress.
- Subscription telehealth for ongoing meds: Revenue is tied to refill behavior and clinical appropriateness, not one-time gift cycles.
Recurring revenue mechanics are covered in depth in why telehealth clinics can be recurring-revenue assets. The asset class comparison for capital structure is in telehealth vs traditional healthcare investing.
Which clinic models tend to be more defensive?
Not all telehealth SKUs behave the same in downturns. Models that often show relative resilience share traits:
- Ongoing medication with clear clinical indication and follow-up cadence
- Diversified formulary rather than single-SKU dependence
- Strong retention operations: reminders, portal UX, support for side effects and titration
- Compliance and ad eligibility that do not break when platforms tighten policy
Beauty-adjacent or purely discretionary positioning without clinical continuity tends to behave more like retail. Operators should know which side of that line they occupy before calling the model "defensive."
Common misconceptions
"Patients stop buying care in a downturn"
They may delay elective spend. Chronic medications, weight-health programs, and mental health support often continue because stopping has real costs. Some patients switch to cash-pay telehealth when employer coverage changes after layoffs, which can hurt or help depending on offer positioning.
"All telehealth categories are equally defensive"
They are not. Diversified medication menus are usually more resilient than a single fragile SKU. Concentration in one compound or one ad channel increases cyclical risk even when the category headline looks strong.
"Category resilience means my clinic is safe"
No. Account health, LegitScript status, ad-platform policy, pharmacy supply, and retention still determine outcomes. See why compliance is a moat in telehealth and patient retention in subscription telehealth.
Historical recessions and healthcare spending patterns
The 2008 financial crisis slowed healthcare spending growth but did not erase it. CMS and academic retrospective work shows patients traded down, delayed electives, and sought lower-cost settings when possible. Telehealth was immature then, so the channel shift lesson is mostly post-2010. Still, the inelastic core held: chronic medications and necessary follow-ups continued.
More recent inflationary pressure in 2022 and 2023 pushed households to scrutinize subscriptions, including cash-pay health offers. Clinics with clear outcomes messaging and predictable monthly pricing tended to retain better than vague wellness bundles. That pattern mirrors broader consumer behavior: cut fluff, keep what works.
For capital allocators comparing asset classes, healthcare's relative stability is one input. Telehealth's share gain within healthcare is another. You need both to underwrite a digital clinic, not only a macro chart showing GDP contraction.
Cash-pay telehealth when employment and coverage shift
Recessions often correlate with job loss and insurance churn. That can push patients toward cash-pay telehealth for categories they still prioritize, such as mental health or weight management, while reducing spend on purely discretionary add-ons. Clinics positioned as clinically necessary with transparent pricing can pick up share from patients who lost employer coverage but maintain therapy.
The same dynamic creates headwinds for premium upsells without clinical justification. Operators should model mixed scenarios: retention holds for core meds, acquisition costs rise if competitors fight for shrinking discretionary wallets, and compliance scrutiny does not pause because GDP slowed.
What recession resilience does not promise
Defensive traits reduce correlation with discretionary retail. They do not eliminate operational failure. Clinics still blow up from creative fatigue, rising CAC, chargebacks, policy suspensions, and leaky cohorts. Macro tailwinds do not fix broken unit economics. Underwrite retention and margin first, then use category defensiveness as a secondary comfort, not a primary thesis.
Planning capital through a cycle
Operators who survived 2020's demand shock and the post-2021 normalization learned to keep compliance spend fixed while flexing media budgets. That playbook applies to classic recessions too: do not pause clinical support or pharmacy SLAs when CAC rises. Fix funnel quality and retention before cutting the infrastructure that keeps patients on therapy.
Investors comparing telehealth to equities during drawdowns should still diligence seller-level cohorts. Category defensiveness is the macro overlay; retention curves are the asset.
Key takeaways
- Healthcare demand is stickier than most discretionary retail.
- Digital delivery can gain share when households optimize for convenience and value.
- COVID showed rapid adoption and partial permanence, not a temporary fad only.
- Refill-driven subscription models align revenue with ongoing need better than one-off visits.
- Category resilience is not the same as clinic-level safety.
- Compliance, retention, and acquisition quality still dominate outcomes.
Related reading
- How Big Is the U.S. Telehealth Market in 2026?
- Why Telehealth Clinics Can Be Recurring-Revenue Assets
- Telehealth vs Traditional Healthcare Investing
- Patient Retention in Subscription Telehealth
Disclaimer: This article references publicly reported industry research, government health statistics, and widely cited market analyses. Market figures vary by definition of "telehealth," "virtual care," and study methodology. Past performance and category trends are not a guarantee of future results. Individual clinic outcomes depend on medication mix, pricing, retention, capital, compliance, advertising policy, execution, and market conditions. Clinic Builder builds and transfers telehealth businesses. We do not provide medical care or legal advice.
